Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma

被引:0
|
作者
Dosquet, C
Coudert, MC
Lepage, E
Cabane, J
Richard, F
机构
[1] Hop St Louis, Lab Cytokines, Ctr Transfus, F-75475 Paris 10, France
[2] Hop Henri Mondor, Unite Informat Med, F-94010 Creteil, France
[3] Hop St Antoine, Dept Med Interne, F-75012 Paris, France
[4] Hop La Pitie Salpetriere, Dept Urol, F-75013 Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis has an important role in the progression of solid tumors, Therefore, we measured the blood levels (ELISA) of angiogenic factors [basic fibroblast growth factor (bFGF), hepatocyte growth factor/scatter factor, and vascular endothelial growth factor (VEGF)] and soluble adhesion molecules [E-selectin, intercellular adhesion molecule (ICAM-1), platelet endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1] in 76 consecutive patients with untreated renal cell carcinoma and 41 healthy controls to evaluate their prognostic value. The serum levels of bFGF, hepatocyte growth factor, and VEGF were significantly higher in patients with renal cancer than they were in healthy subjects, bFGF and VEGF values were significantly higher in patients with disseminated cancer (N+ and/or MS) than they were in those with undisseminated (M-N-) cancer: median = 27 pg/ml, range = 5-118, n = 15 versus median = 8 pg/ml, range 1-149, n = 61 (P = 10(-4)) for bFGF; and median = 883 pg/ml, range = 200-2317, n = 15 versus median = 278 pg/ml, range = 0-1704, n = 61 (P = 0.006) for VEGF, The blood levels of ICAM-1 and vascular cell adhesion molecule-1 were significantly higher, and the levels of E-selectin and platelet endothelial cell adhesion molecule-1 were significantly lower in patients with renal cancer than they were in controls, Plasma ICAM-1 was higher in metastatic patients (M+) than they were in nonmetastatic (M-) patients: median = 687 ng/ml, range = 294-1091, n = 12 versus median = 408 ng/ml, range = 217-1375, n = 64 (P = 10(-4)), ICAM-1 and bFGF blood values were correlated with the size of the primary tumor, The interleukin 6 and tumor necrosis factor-alpha (TNF-alpha) values of these patients have been previously published and are included in the survival analysis, Univariate analysis showed that bFGF, ICAM-1, interleukin 6, and TNF-alpha, before treatment, were prognostic factors, In multivariate analysis for proportional hazard regression, only TNF-alpha was an independent prognostic indicator, with a normal plasma TNF-alpha being highly predictive for a good prognosis in patients with untreated renal cell carcinoma.
引用
收藏
页码:2451 / 2458
页数:8
相关论文
共 50 条
  • [41] Expression of cytokines, growth factors, and adhesion molecules in rejecting human renal allograft
    Loong, CC
    Chen, A
    Lui, WY
    King, KL
    Lin, CY
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1445 - 1446
  • [42] Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-α: association of pretreatment serum levels with survival
    Montero, A. J.
    Diaz-Montero, C. M.
    Millikan, R. E.
    Liu, J.
    Do, K. -A.
    Hodges, S.
    Jonasch, E.
    McIntyre, B. W.
    Hwu, P.
    Tannir, N.
    ANNALS OF ONCOLOGY, 2009, 20 (10) : 1682 - 1687
  • [43] What are the prognostic factors for survival in patients with metastatic renal cell carcinoma?
    Brian I Rini
    Nature Clinical Practice Oncology, 2005, 2 : 292 - 293
  • [44] PROGNOSTIC FACTORS OF METASTATIC RENAL CELL CARCINOMA PATIENTS IN THE IMMUNOTHERAPY ERA
    La Russa, F.
    Riolfi, M.
    Sava, T.
    Ghimenton, C.
    Porcaro, A.
    Cesaro, G.
    Consoli, F.
    Manno, P.
    Pavarana, M.
    Cetto, G. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 197 - 197
  • [45] Current status of prognostic factors in patients with metastatic renal cell carcinoma
    Teishima, Jun
    Inoue, Shogo
    Hayashi, Tetsutaro
    Matsubara, Akio
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (06) : 608 - 617
  • [46] The Prognostic Factors for Patients with pT1a Renal Cell Carcinoma
    Kim, Jong Min
    Song, Phil Hyun
    Kim, Hyun Tae
    Park, Tong Choon
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (04) : 233 - 238
  • [47] Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma
    Shinohara, Nobuo
    Abe, Takashige
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (10) : 888 - 897
  • [48] Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing
    Peccatori, J.
    Barkholt, L.
    Demirer, T.
    Sormani, M. P.
    Bruzzi, P.
    Ciceri, F.
    Zambelli, A.
    Da Prada, G. A.
    Pedrazzoli, P.
    Siena, S.
    Massenkeil, G.
    Martino, R.
    Lenhoff, S.
    Corradini, P.
    Rosti, G.
    Ringden, O.
    Bregni, M.
    Niederwieser, D.
    ANNALS OF ONCOLOGY, 2006, 17 : XI75 - XI76
  • [49] Plasma cytokines and angiogenic factors (CAFs) for evaluation of risk of recurrence and classification of patients (pts) with nonmetastatic renal cell carcinoma (RCC).
    Khajavi, Mehrdad
    Jonasch, Eric
    Wang, Xuemei
    Wood, Christopher G.
    Matin, Surena F.
    Fiorentino, Stefania
    McKee, Kathryn S.
    Tran, Hai T.
    Heymach, John
    Zurita, Amado J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] What are the prognostic factors for survival in patients with metastatic renal cell carcinoma?
    Rini, BI
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 292 - 293